Dionis Minev, PhD
Associate
About
Dionis Minev is an Associate at Fine Structure Ventures, where he focuses on investments in biology, aerospace, and computing.
Before joining FSV, Dionis was a Senior Scientist at an early-stage DNA data storage and computing startup, where he led technology development before moving into business development and product management.
He completed his PhD and Postdoctoral work with William Shih at Harvard, conducting research at the Wyss Institute and Dana-Farber Cancer Institute, and later continued as a Staff Scientist on the Wyss’ Molecular Robotics Platform. His work focused on the self-assembly of DNA nanostructures and their applications in diagnostics. Dionis began his career in mechanical engineering, including time at Airbus, before moving into bioengineering and synthetic biology.
He earned his Ph.D. in Engineering Sciences from Harvard University, a B.S. in Mechanical Engineering from the Karlsruhe Institute of Technology, and a master’s degree in Medical Engineering and Technology from the Technical University of Munich.
-
At Constructive Bio, they rewrite the genome to build the biomolecules of the future. Their unique technology transforms living cells into biofactories, producing sustainable new materials and therapeutics. With complete control over the genetic sequence and code, they are exploring chemical space that natural biology has not previously accessed.
Learn more at constructive.bio.
-
Category
- Biology
-
Status
- Fund II
-
Location
Cambridge, UK
-
Year Invested
2024
-
Team
-
-
Debut uses a proprietary platform technology called cell-free biomanufacturing to unlock and overcome the limitations of cell-based techniques. This process retains the useful parts of the cell, such as enzymes, and discards the limiting parts of the cell to overcome the barriers of traditional biomanufacturing. Debut provides access to complex and high-value ingredients for a vast number of markets.
Learn more at debutbiotech.com.
-
Category
- Biology
-
Status
- Fund I
-
Location
San Diego, CA
-
Year Invested
2021
-
Team
-
-
Fat is the single most important sensory component in meat, but the plant oils currently used in meat alternatives lack the physical properties and flavor of animal fat. Hoxton Farms combines cell biology and mathematical modeling to produce cultivated animal fat, the key ingredient that will unlock meat alternatives that look, cook, and taste like the real thing.
Learn more at hoxtonfarms.com.
-
Category
- Biology
- ClimateTech
-
Status
- Fund II
-
Location
London, UK
-
Year Invested
2022
-
Team
-
-
Nulixir Inc. is a food tech company that specializes in nutrition and functional ingredients through use of its patented Smart Delivery technology. Nulixir collaborates with business-to-business (B2B) ingredient suppliers looking to take their branded ingredients to additional markets and applications through taste, solubility, stability, and bioavailability improvement. In addition, Nulixir works with brand owners of consumer-packaged goods (CPG) to incorporate the Smart Delivery technology to create highly experiential functional products with appealing taste profiles. Nulixir is headquartered and has manufacturing in Austin, Texas.
Learn more at nulixir.com
-
Category
- Biology
-
Status
- Fund II
-
Year Invested
2023
-
Team
-
-
Modern agriculture faces increasing challenges due to climate change and population growth. Humanity needs to produce more food to sustain a growing population while significantly reducing emissions. Current methods to improve crops are severely limited by development time and cost. Phytoform’s technology significantly speeds up trait development and implementation, producing new plant traits in months rather than years, and at a fraction of the cost of conventional breeding and GMO technologies.
Learn more at phytoformlabs.com.
-
Category
- Biology
- ClimateTech
-
Status
- Fund I
-
Location
Harpenden, UK and Somerville, MA
-
Year Invested
2021
-
Team
-
